Belite Bio (BLTE) Accumulated Expenses (2021 - 2025)

Belite Bio's Accumulated Expenses history runs 5 years deep, the most recent figure standing at $1.6 million for Q4 2025.

• In Q4 2025, Accumulated Expenses rose 129.02% year-over-year to $1.6 million; the TTM figure through Dec 2025 stood at $1.6 million (up 129.02% YoY), while the FY2025 annual figure was $1.6 million, up 129.02% from the prior year.
• Accumulated Expenses for Q4 2025 stood at $1.6 million, down from $7.8 million in the prior quarter.
• The five-year high for Accumulated Expenses was $7.8 million in Q3 2025, with the low at $56000.0 in Q4 2021.
• The 5-year median for Accumulated Expenses is $1.8 million (2022), against an average of $2.6 million.
• The sharpest annual moves came in 2022 and 2024: Accumulated Expenses soared 3303.57% in 2022, then sank 78.86% in 2024.
• Belite Bio's Accumulated Expenses stood at $56000.0 in 2021, then jumped by 3303.57% to $1.9 million in 2022, then soared by 74.45% to $3.3 million in 2023, then tumbled by 78.86% to $703000.0 in 2024, then soared by 129.02% to $1.6 million in 2025.
• Business Quant data shows BLTE's Accumulated Expenses at $1.6 million in Q4 2025, $7.8 million in Q3 2025, and $703000.0 in Q4 2024.